Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Kidney Int
    August 2022
  1. FUCHS MAA, Kurtz A
    The fate of erythropoietin-producing cells: another piece of the puzzle.
    Kidney Int. 2022;102:230-233.
    >> Share

    June 2022
  2. BATTE A, Menon S, Ssenkusu JM, Kiguli S, et al
    Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality.
    Kidney Int. 2022 Jun 16. pii: S0085-2538(22)00453.
    >> Share

  3. VAN DEN BROEK B, van der Flier M, van de Kar NCAJ, Wetzels JFM, et al
    Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C.
    Kidney Int. 2022;101:1293-1295.
    >> Share

  4. WAGENER FADTG, van de Kar NCAJ, van den Heuvel LP
    Protective mechanisms harnessing against injurious heme and preventing kidney damage in STEC-HUS: toward new therapies?
    Kidney Int. 2022;101:1107-1109.
    >> Share

  5. PIRSCHEL W, Mestekemper AN, Wissuwa B, Krieg N, et al
    Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
    Kidney Int. 2022;101:1171-1185.
    >> Share

    May 2022
  6. KANEKO K, Sato Y, Uchino E, Toriu N, et al
    Lineage tracing analysis defines erythropoietin-producing cells as a distinct subpopulation of resident fibroblasts with unique behaviors.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00376.
    >> Share

  7. LABES R, Brinkmann L, Kulow VA, Roegner K, et al
    Daprodustat prevents Cyclosporine-A mediated anemia and peritubular capillary loss.
    Kidney Int. 2022 May 25. pii: S0085-2538(22)00375.
    >> Share

    April 2022
  8. HANUDEL MR, Czaya B, Wong S, Rappaport M, et al
    Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin.
    Kidney Int. 2022;101:711-719.
    >> Share

    The ins and outs of ferric citrate.
    Kidney Int. 2022;101:668-670.
    >> Share

    March 2022
  10. JOLES JA
    Anemia and red blood cell deformability in proteinuric chronic kidney disease.
    Kidney Int. 2022;101:649.
    >> Share

    December 2021
  11. DRUEKE TB, Massy ZA
    Role of proteinuria in the anemia of chronic kidney disease.
    Kidney Int. 2021;100:1160-1162.
    >> Share

    September 2021
  12. BISSINGER R, Nemkov T, D Alessandro A, Grau M, et al
    Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism.
    Kidney Int. 2021 Sep 16. pii: S0085-2538(21)00858.
    >> Share

    August 2021
  13. LILL JK, Thiebes S, Pohl JM, Bottek J, et al
    Tissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome.
    Kidney Int. 2021;100:349-363.
    >> Share

  14. BOUWMEESTER RN, van de Kar NCAJ, Wetzels JFM
    Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome.
    Kidney Int. 2021;100:265-268.
    >> Share

    July 2021
  15. SCIESIELSKI LK, Felten M, Michalick L, Kirschner KM, et al
    The circadian clock regulates rhythmic erythropoietin expression in the murine kidney.
    Kidney Int. 2021 Jul 29. pii: S0085-2538(21)00729.
    >> Share

  16. IKEDA Y
    Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23.
    Kidney Int. 2021;100:14-16.
    >> Share

  17. ARICETA G, Dixon BP, Kim SH, Kapur G, et al
    The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment.
    Kidney Int. 2021;100:225-237.
    >> Share

    June 2021
  18. KOYUN M, Kaya Aksoy G, Comak E, Ozaltin F, et al
    Outcome of diacylglycerol kinase epsilon-mediated hemolytic uremic syndrome in an infant.
    Kidney Int. 2021;99:1500-1501.
    >> Share

    April 2021
  19. BABITT JL, Eisenga MF, Haase VH, Kshirsagar AV, et al
    Controversies in Optimal Anemia Management: Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Conference.
    Kidney Int. 2021 Apr 8. pii: S0085-2538(21)00355.
    >> Share

    March 2021
  20. HANUDEL MR, Wong S, Jung G, Qiao B, et al
    Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Kidney Int. 2021 Mar 31. pii: S0085-2538(21)00354.
    >> Share

  21. FUCHS MAA, Broeker KAE, Schrankl J, Burzlaff N, et al
    Inhibition of transforming growth factor beta1 signaling in resident interstitial cells attenuates profibrotic gene expression and preserves erythropoietin production during experimental kidney fibrosis in mice.
    Kidney Int. 2021 Mar 8. pii: S0085-2538(21)00278.
    >> Share

    January 2021
  22. VILLE S, Le Bot S, Chapelet-Debout A, Blancho G, et al
    Atypical HUS relapse triggered by COVID-19.
    Kidney Int. 2021;99:267-268.
    >> Share

    November 2020
  23. NORIS M, Remuzzi G
    Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?
    Kidney Int. 2020;98:1084-1087.
    >> Share

  24. HASSANEIN M, Liaqat A, Paratore DA, Vachharajani TJ, et al
    The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis.
    Kidney Int. 2020;98:1357-1358.
    >> Share

    May 2020
  25. BROEKER KAE, Fuchs MAA, Schrankl J, Kurt B, et al
    Different subpopulations of kidney interstitial cells produce erythropoietin and factors supporting tissue oxygenation in response to hypoxia in vivo.
    Kidney Int. 2020 May 23. pii: S0085-2538(20)30542.
    >> Share

    April 2020
  26. WYATT CM, Drueke TB
    Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.
    Kidney Int. 2020;97:639-642.
    >> Share

    December 2019
    Ferric citrate: cardio- and renoprotective in chronic kidney disease?
    Kidney Int. 2019;96:1277-1279.
    >> Share

    November 2019
  28. EL KAROUI K, Boudhabhay I, Fremeaux-Bacchi V
    Atypical hemolytic uremic syndrome and hypertensive crisis.
    Kidney Int. 2019;96:1239.
    >> Share

    May 2019
  29. CAVERO T, Arjona E, Soto K, Caravaca-Fontan F, et al
    Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
    Kidney Int. 2019 May 31. pii: S0085-2538(19)30582.
    >> Share

  30. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    >> Share

    April 2019
  31. DUINEVELD C, Wijnsma KL, Volokhina EB, van den Heuvel LPB, et al
    Placental passage of eculizumab and complement blockade in a newborn.
    Kidney Int. 2019;95:996.
    >> Share

    February 2019
  32. IMERI F, Nolan KA, Bapst AM, Santambrogio S, et al
    Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype.
    Kidney Int. 2019;95:375-387.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016